These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 15251321

  • 1. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y, Oka K, Moriyama T, Ichimaru N, Kyo M, Kokado Y, Ito T, Imai E, Aozasa K, Okuyama A, Takahara S.
    Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
    [Abstract] [Full Text] [Related]

  • 2. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK.
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [Abstract] [Full Text] [Related]

  • 3. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE, McNamee PT, Nelson WE, Maxwell AP.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [Abstract] [Full Text] [Related]

  • 4. The fate of renal transplants in patients with IgA nephropathy.
    Frohnert PP, Donadio JV, Velosa JA, Holley KE, Sterioff S.
    Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
    [Abstract] [Full Text] [Related]

  • 5. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Apr; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 6. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [Abstract] [Full Text] [Related]

  • 7. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.
    Ng YS, Vathsala A, Chew ST, Chiang GS, Woo KT.
    Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440
    [Abstract] [Full Text] [Related]

  • 8. IgA nephropathy in kidney allograft recipients-therapeutic perspective.
    Pazik J, Baczkowska T, Lewandowski Z, Lewandowska D, Ostrowska J, Perkowska Ptasińska A, Mróz A, Miszewska-Szyszkowska D, Rowinski W, Durlik M.
    Transplant Proc; 2006 Jun; 38(1):112-4. PubMed ID: 16504678
    [Abstract] [Full Text] [Related]

  • 9. Influence of interleukin-10 gene G-1082A polymorphism on recurrent IgA nephropathy.
    Bantis C, Heering PJ, Aker S, Schwandt C, Grabensee B, Ivens K.
    J Nephrol; 2008 Jun; 21(6):941-6. PubMed ID: 19034880
    [Abstract] [Full Text] [Related]

  • 10. Recurrence of IgA nephropathy among renal allograft recipients from living donors is greater among those with zero HLA mismatches.
    McDonald SP, Russ GR.
    Transplantation; 2006 Sep 27; 82(6):759-62. PubMed ID: 17006322
    [Abstract] [Full Text] [Related]

  • 11. Clinical remission and pathological progression after tonsillectomy in a renal transplant patient with recurrent IgA nephropathy.
    Sakai K, Saneshige M, Takasu J, Yanagisawa T, Aoki Y, Kawamura T, Mizuiri S, Aikawa A.
    Clin Transplant; 2009 Aug 27; 23 Suppl 20():44-8. PubMed ID: 19594596
    [Abstract] [Full Text] [Related]

  • 12. Progression of renal allograft histology after renal transplantation in recurrent and nonrecurrent immunoglobulin A nephropathy.
    Jeong HJ, Park SK, Cho YM, Kim MS, Kim YS, Choi J, Kim SI, Lim BJ.
    Hum Pathol; 2008 Oct 27; 39(10):1511-8. PubMed ID: 18620732
    [Abstract] [Full Text] [Related]

  • 13. [A clinicopathological study of recurrent IgA nephropathy following renal transplantation].
    Matsugami K, Naito T, Nitta K, Nihei H, Tanabe K, Toma H, Yamaguchi Y.
    Nihon Jinzo Gakkai Shi; 1998 Jul 27; 40(5):322-8. PubMed ID: 9752688
    [Abstract] [Full Text] [Related]

  • 14. Two cases of recurrent IgA nephropathy following kidney transplantation.
    Kishi Y, Takai K, Akao J, Isoyama N, Matsumura M, Uchiyama K, Tsuchida M, Suga A, Naito K.
    Transplant Proc; 2004 Sep 27; 36(7):2160-1. PubMed ID: 15518785
    [Abstract] [Full Text] [Related]

  • 15. Recurrent mesangial IgA nephritis following renal transplantation.
    Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ.
    Nephrol Dial Transplant; 1994 Sep 27; 9(3):309-12. PubMed ID: 8052439
    [Abstract] [Full Text] [Related]

  • 16. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F, Gelpi R, Koskinen P, Manonelles A, Räisänen-Sokolowski A, Carrera M, Honkanen E, Grinyó JM, Cruzado JM.
    Nephrol Dial Transplant; 2012 Jun 27; 27(6):2553-8. PubMed ID: 22167589
    [Abstract] [Full Text] [Related]

  • 17. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS.
    Transpl Int; 2010 Feb 27; 23(2):169-75. PubMed ID: 19761553
    [Abstract] [Full Text] [Related]

  • 18. Recurrence of IgA nephropathy 17 months after renal transplantation in the allograft transmitted thin basement membrane disease (TBMD) from donor.
    Nakagawa Y, Saito K, Nishi S, Bilim V, Tanikawa T, Ueno M, Shimada H, Osawa Y, Arakawa M, Takahashi K.
    Clin Transplant; 1999 Feb 27; 13 Suppl 1():59-62. PubMed ID: 10751059
    [Abstract] [Full Text] [Related]

  • 19. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P.
    Nephrol Dial Transplant; 2013 May 27; 28(5):1305-14. PubMed ID: 23229925
    [Abstract] [Full Text] [Related]

  • 20. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X, Johnston A.
    Transplant Proc; 2004 Dec 27; 36(10):2993-6. PubMed ID: 15686679
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.